Home » Topics » BioWorld Science

BioWorld Science
RSS

Clinical response found with eculizumab in rheumatoid arthritis

June 17, 2004

Preliminary data on the efficacy of epratuzumab in SLE

June 17, 2004

New monoamine reuptake inhibitors developed at NeuroSearch

June 17, 2004

Novel chemokine CCR1 antagonists and their use covered by Pfizer patent

June 17, 2004

T-614 reported safe and effective in patients with active rheumatoid arthritis

June 17, 2004

Dual alpha7 nAChR agonists/5-HT3 antagonists for psychosis, cognition disorders, etc.

June 17, 2004

New antilipolytic agents targeting hRUP38 receptors

June 17, 2004

Boehringer Ingelheim scientists describe new ICAM-1/LFA-1 interaction inhibitors

June 17, 2004

Two series of gamma-secretase inhibitors identified at Merck

June 17, 2004

AstraZeneca presents novel PTP-1B inhibitors

June 17, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists
BioWorld Science
Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...